Adverum Biotechnologies I... (ADVM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.72
0.47 (11.06%)
At close: Jan 15, 2025, 3:54 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 3.60M | n/a | 7.50M | n/a | 250.00K | 1.61M | 1.85M | 1.46M | 2.32M | 572.00K | 480.00K | 30.00K |
Cost of Revenue | 5.64M | 6.53M | 4.64M | 4.16M | n/a | n/a | 2.10M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -2.04M | -6.53M | 2.85M | -4.16M | 250.00K | 1.61M | -247.00K | 1.46M | 2.32M | 572.00K | 480.00K | 30.00K |
Operating Income | -123.99M | -157.13M | -146.12M | -117.95M | -68.55M | -78.08M | -58.85M | -115.28M | -47.82M | -24.40M | -3.45M | -1.82M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -118.24M | -154.46M | -145.54M | -116.39M | -64.49M | -73.88M | -56.15M | -114.52M | -47.45M | -25.40M | -5.28M | -1.81M |
Net Income | -117.17M | -154.54M | -145.54M | -117.51M | -64.49M | -72.63M | -56.15M | -113.75M | -47.45M | -25.40M | -5.28M | -1.81M |
Selling & General & Admin | 49.91M | 57.86M | 64.44M | 44.64M | 28.38M | 24.56M | 20.86M | 24.36M | 22.11M | 8.00M | 1.78M | 536.00K |
Research & Development | 77.48M | 99.28M | 89.18M | 73.31M | 40.42M | 50.13M | 39.84M | 31.67M | 25.46M | 16.98M | 2.15M | 1.31M |
Other Expenses | n/a | 2.67M | 582.00K | 1.56M | 4.06M | 4.20M | 2.70M | 762.00K | 370.00K | -1.00M | -96.00K | -6.00K |
Operating Expenses | 127.59M | 157.13M | 153.62M | 117.95M | 68.80M | 74.69M | 60.70M | 56.02M | 47.57M | 24.97M | 3.45M | 1.82M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.00K | 73.00K | 8.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 127.59M | 157.13M | 153.62M | 117.95M | 68.80M | 74.69M | 60.70M | 56.02M | 47.57M | 24.97M | 3.45M | 1.82M |
Income Tax | -1.08M | 74.00K | 4.41M | 1.11M | 1.40M | -1.25M | n/a | -775.00K | 1.76M | -162.00K | -23.00K | 2.00K |
Shares Outstanding (Basic) | 10.08M | 9.93M | 9.80M | 8.51M | 6.41M | 61.38M | 43.66M | 36.25M | 25.48M | 22.75M | 20.78M | 20.78M |
Shares Outstanding (Diluted) | 10.08M | 9.93M | 9.80M | 8.51M | 6.41M | 61.38M | 43.66M | 36.25M | 25.86M | 22.75M | 20.78M | 20.78M |
EPS (Basic) | -11.62 | -15.57 | -14.85 | -13.8 | -10.06 | -1.18 | -1.29 | -3.14 | -1.86 | -1.12 | -0.25 | -0.09 |
EPS (Diluted) | -11.62 | -15.57 | -14.85 | -13.8 | -10.06 | -1.18 | -1.29 | -3.14 | -1.84 | -1.12 | -0.25 | -0.09 |
EBITDA | -118.35M | -147.93M | -140.90M | -112.23M | -62.91M | -72.13M | -54.05M | -52.97M | -46.74M | -25.22M | -3.52M | -1.82M |
Depreciation & Amortization | 5.64M | 6.53M | 4.64M | 4.16M | 1.57M | 1.75M | 2.10M | 1.60M | 812.00K | 162.00K | 26.00K | 1K |